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Abstract
Background: Pancreatic cancer is one of the most aggressive and mortal cancers. Although several drugs have been
proposed for its treatment, it remains resistant and new alternatives are needed. In this context, plants and their
derivatives constitute a relevant source of bioactive components which might efficiently inhibit tumor cell progression.
Methods: In this study, we have analyzed the potential anti-carcinogenic effect of different Asteraceae (Achillea millefolium
and Calendula officinalis) and Lamiaceae (Melissa officinalis and Origanum majorana) plant extracts obtained by different
green technologies (Supercritical CO2 Extraction –SFE- and Ultrasonic Assisted Extraction –UAE-) to identify efficient plant
extracts against human pancreatic cancer cells that could constitute the basis of novel treatment approaches.
Results: Asteraceae extracts showed better results as antitumoral agents than Lamiaceae by inducing cytotoxicity and
inhibiting cell transformation, and SFE extracts were most efficient than UAE extracts. In addition, SFE derived plant extracts
from Achillea millefolium and Calendula officinalis displayed synergism with the chemotherapeutic 5-Fluororacil.
Conclusion: These results show how Yarrow and Marigold SFE-derived extracts can inhibit pancreatic cancer cell growth,
and could be proposed for a comprehensive study to determine the molecular mechanisms involved in their bioactivity
with the final aim to propose them as potential adjuvants in pancreatic cancer therapy.
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Background
As reported by the European Society for Medical Oncol-
ogy (ESMO), pancreatic cancer is the seventh most com-
mon cancer in Europe, accounting for 2.8% of cancer in
men and 3.2% in women. It is the fifth leading cause
cancer-related death with 70,000 estimated deaths each
year [1]. Depending on the tumor stage and if surgery is
possible, current treatments are based on the use of the
antimetabolite 5-fluorouracil (5-FU), but also gemcita-
bine, nab-paclitaxel, or in combination with acid folic,
such as Folfirinox (folic acid+ 5-FU or irinotecan or oxa-
liplatin) [2]. A reduced percentage of patients respond to
these antitumor agents due to the advanced stage of the
tumor when it is diagnosticated and due to the appear-
ance of resistances. In this scenario, plants are an im-
portant source to obtain new compounds that could be
used as chemotherapeutic drugs.
In the last decades, plant-derived compounds have
been clinically used as anti-cancer agents [3, 4], as they
demonstrate the ability to modulate several molecular
pathways involved in tumor development and progres-
sion. In this sense, the expected intervention for a
plant-derived extract as antitumoral agent should exert a
cytotoxic effect in tumor cells, without affecting cell via-
bility of normal cells.
In a recent work, we produced and chemically charac-
terized several extracts obtained from Lamiaceae (Melissa
officinalis or Balm and Origanum majorana or Marjoram)
and Asteraceae (Achillea millefolium or Yarrow, and
Calendula officinalis or Marigold) plant families. For this
purpose, we produced two different extracts from each
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plant by applying two sequential extraction steps: first
Supercritical Fluid Extraction (SFE) and then, the
remained vegetal raw material was re-extracted by Ultra-
sonic Assisted Extraction (UAE) [5].
Herein, in the present work, we investigated the anti-
tumoral activity of those extracts obtained from Balm,
Marjoram, Yarrow and Marigold SFE and UAE extracts
in pancreatic cancer cell lines models (MIA PaCa-2 and
PANC-1), and we have compared their biological activity
and efficiency between the two extraction approaches
(Fig. 1). Furthermore, additional UAE extracts were pro-
duced using the original vegetal matrix (OVM) for com-
parison with those produced previously [4] using the
SFE residual vegetal matrix (RVM).
Although previous works have been described the anti-
tumoral properties exerted by Marjoram [6, 7], Balm [8,
9], Yarrow [10, 11], and Marigold [12, 13], to our know-
ledge, the novelty of the present work lies in the analysis
of extracts produced by environmentally friendly extrac-
tion techniques together with advanced biological
methods in order to obtain, test and characterize natural
extracts that could be potentially used for cancer therap-
ies. After identifying the most efficient extracts inducing
pancreatic cells toxicity, we further studied the
mechanisms through which they induce cell death (apop-
tosis or necrosis) and their potentiality to inhibit cell ma-
lignancy and invasion. We also have evaluated the
putative synergism with 5-FU to propose an efficient anti-
tumoral product as a potential adjuvant in pancreatic can-
cer treatment. Our findings indicate that the SFE extracts
obtained from Yarrow and Marigold meet the require-




DMEM (Dulbecco’s Modified Eagle Medium), PBS
(Phosphate-buffered saline), glutamine and trypsin were
purchased from Lonza Spain; and FBS from Thermo
Fisher Scientific. DMSO (Dimethyl Sulfoxide) and Etha-
nol were purchased from Scharlab S.L. MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) and Staurosporine were purchased from Sigma
Aldrich. Plants leaves for producing the extracts were
purchased from Herboristería Murciana (Murcia, Spain),
and commercial extracts were purchased from Soria
Natural, S.A.
Fig. 1 Screening overview and general approach addressed in the present work
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Extraction procedures
Extracts were obtained by mean of two different green
technologies as described previously [[5]]. Briefly, SFE
was carried out using supercritical CO2 (140 bar, 40 °C,
70 g CO2/min), and UAE derived extracts using ethanol
or ethanol: water − 50:50- (70 Hz, 30 °C). In addition,
and regarding UAE, two different extracts were
compared in the present work: the extracts produced
from the Original Vegetable Matrix (OVM) and the
those produced from the Residual Vegetable Matrix
(RVM) after the SFE extraction. Fig. 1 shows a schematic
overview of all the extracts evaluated in this study.
Chemical composition of the extracts is described in a
previous work [4]. The extracts obtained by ultrasonic
Fig. 2 Dose-response curves of cell viability assays after 48 h treatment of MIA PaCa-2 human pancreatic cancer cells with increasing concentrations of
SFE extracts (a), UAE (Ethanol) MVR extracts (b), UAE (Ethanol:Water) MVR extracts (c), UAE (Ethanol:Water) MVO extracts (d), UAE (Ethanol) MVO extracts
(e) and commercial extracts (f). Data represent means ± S.E.M of at least three independent experiments each performed in quadruplicate. Asterisks
indicate statistical differences in treated cells with respect to the control (non-treated cells, DMSO 0.1%). *p < 0.05; **p < 0.01; ***p < 0.001
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probe are rich in flavonoids and phenols, whereas those
obtained by supercritical CO2 are rich in sesquiterpenes
and monoterpenes, which were detailed by a
gas-chromatography analysis [4].
Cell culture
Human pancreatic cancer cells MIA PaCa-2 and PANC-1,
obtained from American Type Culture Collection (ATCC),
were cultured in DMEM supplemented with 10% FBS.
Cells were kept under standard conditions of temperature
(37 °C), humidity (95%) and carbon dioxide (5%).
For tridimensional culture, MIA PaCa-2 cells were
grown in Matrigel Growth Factor Reduced (Corning®
Life Sciences) 80%, and media was renewed every two
days, until the 3D-spheres were formed. Treatments
with extracts were then applied for 72 h.
Cell viability assay
The cytotoxic and antiproliferative activities of the dif-
ferent extracts in human pancreatic tumor cell lines
were determined by MTT assay. Briefly, cells in the ex-
ponential growth phase were plated in 96-multiwell
plates. After 24 h, media was replaced with 200 μL
media containing serial concentrations of each extract
(dissolved in DMSO) for 48 h. The number of viable
cells was determined at time zero (control growth wells)
and after treatments. To determine the number of viable
cells, tetrazolium MTT salt solution (Sigma) (5 mg/mL
in phosphate- buffered saline) was added for 3 h. Then,
the formazan produced in each well was solubilized by
adding 200 μL DMSO and measured using a spectro-
photometer reader (λ = 560 nm) (Biochrom Asys UVM
340 Microplate Reader; ISOGEN). Parameters for 50% of
cell viability inhibition (IC50), 50% of cell growth inhib-
ition (GI50), total cell growth inhibition (TGI), and 50%
of cell death (LC50) were calculated accordingly to NIH
definitions using a logistic regression [14].
The synergism between 5-FU and Yarrow and Mari-
gold SFE extracts was analyzed by the combination
index (CI) obtained using the Calcusyn software (Bio-
soft), based on the Chou-Talalay method [15].
Flow cytometry
After 24 h’ culture in DMEM, pancreatic cancer MIA
PaCa-2 cells were treated with increasing concentrations
of Yarrow and Marigold SFE extracts for 24 h. Marjoram
SFE extract was used as a negative control and stauros-
porine 1.5 μM as a positive control for apoptosis. The
Annexin V and Propidium iodide (PI) staining was car-
ried out by using Annexin V-FITC Apoptosis Detection
Table 1 Concentration parameters of the selected plant extracts on MIA PaCa-2 cell line sensitivity depending on the extraction method
Extraction Method
SFE UAE Commercial
Concentration Parameter RVM OVM
Plant extract Ethanol Ethanol:Water Ethanol Ethanol:Water
Marjoram IC50 > 100a > 100a > 100a – > 100 –
GI50 > 100 75,89 ± 2,05 > 100 – > 100 –
TGI > 100 > 100 > 100 – > 100 –
LC50 > 100 > 100 > 100 – > 100 –
Balm IC50 > 100a > 100a > 100a – > 100 –
GI50 > 100 > 100 > 100 – > 100 –
TGI > 100 > 100 > 100 – > 100 –
LC50 > 100 > 100 > 100 – > 100 –
Yarrow IC50 31,4 ± 8,5a 48,5 ± 2,5a > 100 28,8 ± 15,8 > 100 > 500
GI50 37,4 ± 7,3 > 100 > 100 49,4 ± 25,7 > 100 > 500
TGI 56 ± 1,4 65,1 ± 6,1 > 100 86,6 ± 3,4 > 100 > 500
LC50 70,6 ± 7,1 > 100 > 100 > 100 > 100 > 500
Marigold IC50 39,8 ± 4,6a > 100a > 100a – > 100 > 500
GI50 – > 100 > 100 – > 100 > 500
TGI 54, ± 3,1 > 100 > 100 – > 100 > 500
LC50 78,5 ± 1,4 > 100 > 100 – > 100 > 500
Data (> 100): not significant activity found at 100 μg/mL concentration; (−): not determined; SFE Supercritical Fluid Extraction, UAE Ultrasound Assisted Extraction,
RVM Residual Vegetable Matrix, OVM Original Vegetable Matrix. aData acquired from a previous work [4]
Data are presented as IC50 (μg/mL) (concentration needed to induce 50% cell viability inhibition [4, 5] <sup> 5</sup>, GI50 (μg/mL) (concentration needed for
50% growth inhibition), TGI (μg/mL) (concentration needed for total growth inhibition) and LC50 (μg/mL) (concentration needed for 50% cell death) after 48 h
treatment as mean ± SEM of at least three independent experiments each performed in quadruplicate
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kit (Immunostep, Spain) accordingly to manufacturer’s
instructions. Stained cells were conducted on a Cytomics
FC500 (Beckam Coulter) cytometer. Early apoptosis was
defined as Ann+/PI- cells, whereas Ann+/PI+ cells was
defined as late apoptosis and Ann-/PI+ cells were con-
sidered as necrotic cells.
Caspase activation assay
MIA Paca-2 cells were plated in 96-multiwell and
treated for 48 h with increasing concentrations of the
extracts. The activation of caspase 3 and caspase 7 was
determined using the Caspase-Glo 3/7 assay kit
(Promega), following manufacturer’s instructions.
Statistical analysis
Results were analyzed by ANOVA non-parametric with
Bonferroni post hoc tests. Data were represented as mean
± S.E.M of at least three independent experiments. Statis-
tical differences were defined as p < 0,05. Statistical analysis
was performed with Graph Pad Prim 6 statistical software.
Results
Effect of Asteraceae and Lamiaceae families plant derived
extracts on MiaPaca-2 cell viability
We first determined the effect of all extracts on MIA
PaCa-2 cell viability by MTTassay. In this assay, viable cells
with active metabolism can convert MTT into a colored
product by reducing the MTT into formazan [16]. MIA
PaCa-2 cells were treated for 48 h with all extracts in a
range of concentrations between 0 and 100 μg/ml. As
observed in Fig. 2a, Yarrow and Marigold SFE extracts
decreased cell viability in a dose-dependent manner (IC50
= 31,5 ± 8,6 μg/mL and 39,8 ± 4,6 μg/mL respectively [5]),
while Balm and Marjoram SFE extracts did not affected cell
viability at any of the doses tested.
Regarding UAE (Ethanol), Yarrow extracts, both obtained
from RVM and from OVM, inhibited cell proliferation in a
Fig. 3 Dose-response curves of cell viability assays after 48 h treatment
of PANC-1 pancreatic cancer cells with increasing concentrations of
SFE extracts (a), UAE (Ethanol) MVO extracts (b) and commercial
extracts (c) for PANC-1. Data represent means ± S.E.M of at least three
independent experiments each performed in quadruplicate. Asterisks
indicate statistical differences in treated cells with respect to the
control (non-treated cells, DMSO 0.1%). ***p < 0.001
Table 2 Concentration parameters of the selected plant extracts







Marjoram IC50 > 100 – –
GI50 > 100 – –
TGI > 100 – –
LC50 > 100 – –
Yarrow IC50 > 100 > 100 > 500
GI50 24,5 ± 0,26 > 100 > 500
TGI 96,4 ± 6,2 69,2 ± 1,1 > 500
LC50 > 100 > 100 > 500
Marigold IC50 43,2 ± 7,9 – > 500
GI50 > 100 – > 500
TGI 45,9 ± 1,8 – > 500
LC50 74,2 ± 6,6 – > 500
Data (> 100): not significant activity found at 100 μg/mL concentration; (−): not
determined; SFE Supercritical Fluid Extraction, UAE Ultrasound Assisted
Extraction, OVM Original Vegetable Matrix
Data are presented as IC50 (μg/mL) (concentration needed for 50% inhibition
of cell proliferation), GI50 (μg/mL) (concentration needed for 50% growth
inhibition), TGI (μg/mL) (concentration needed for total growth inhibition) and
LC50 (μg/mL) (concentration needed for 50% cell death) after 48 h’ treatment
as mean ± SEM of at least three independent experiments each performed
in quadruplicate
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higher manner than the rest of the UAE plant extracts
(Marigold, Marjoram and Balm) (Fig. 2b, e). We also
checked UAE extracts obtained with a mix of ethanol: water
(50:50) as solvent from both vegetal matrices (OVM, RVM),
but none of them affected cell viability in any of the tested
doses (Fig. 2c, d). Table 1 summarizes concentrations corre-
sponding to 50% cell viability inhibition (IC50), 50% cell
growth inhibition (GI50), total cell growth inhibition (TGI),
and 50% of cell death (LC50) for all the extracts tested.
With these preliminary results, SFE extracts from
Asteraceae family (Marigold and Yarrow) seems to com-
promise cell viability by inducing lethal toxicity (Yarrow:
LC50 = 70,6 ± 8,6 μg/mL and Marigold: LC50 = 78,5 ±
1,4 μg/mL) suggesting that these two extracts might act
as promising antitumor agents against pancreatic cancer.
Effect of yarrow and Marigold extracts on PANC-1
metastatic pancreatic cancer cell line
We next studied the effect of the most effective ex-
tracts from Asteraceae plants (Yarrow SFE and Mari-
gold SFE) on PANC-1 pancreatic cancer cell line,
described to be more resistant to treatments [14, 15].
As shown in Fig. 3a and Table 2, Marigold displayed
the strongest cell growth inhibition (IC50 = 43,2 ±
7,9 μg/mL) and lethal effect (LC50 = 74,2 ± 6,6), while
Yarrow did not exert any effect at the doses tested
(IC50 > 100 μg/mL).
Regardless UAE derived extracts, we only tested Yar-
row UAE (Ethanol) from the OVM, as it has been shown
to be the most effective UAE extracts tested in MIA
PaCa-2. As shows Fig. 3b, IC50 value was much higher
in PANC-1 compared to MIA PaCa-2 value (Fig. 2b).
In the other hand, we compared the effect on cell via-
bility of commercial extracts obtained industrially by gly-
cerin tincture, with Yarrow and Marigold SFE extracts
and Yarrow UAE (ethanol) OVM extract. As shown in
Tables 1 and 2, commercial extracts from Yarrow or
Marigold did not exerted any effect on cell viability of
MIA PaCa-2 and PANC-1 in the range of the doses
tested (Fig. 2f and Fig. 3c, respectively) (GI50, TGI and
LC50 values were higher than 500 μg/mL).
Finally, we have determined the effect on cell viability in a
non-tumoral cell line (Additional file 1: Table S1, Additional
file 1: Figure S1) to ensure the nontoxic response. The IC50
in the non-tumoral cells is 81,6 ± 14,1 μg/mL for Yarrow and
84,3 ± 21,2 for Marigold SFE extract.
Yarrow and Marigold SFE extracts induce pancreatic
cancer cell death through apoptosis
To assess the mechanism by which Yarrow and Marigold
SFE extracts induce cell growth inhibition, we have ana-
lyzed caspase 3/7 activation and the apoptotic populations.
Firstly, and as shown in Fig. 4, after 48 h of treatment,
both Yarrow and Marigold SFE increased the levels of
active (cleaved) caspases 3/7.
In addition, we have also determined, by flow cytome-
try with Annexin-V and PI staining, the distribution of
apoptotic and necrotic cell subpopulations. Fig. 5a shows
percentages of early apoptotic cells (PI−/Annexin V+),
late apoptotic cells (PI+/Annexin V+) and necrotic cells
(PI+/Annexin V-). Both extracts induced late apoptosis
at 100 μg/mL (Fig. 5a). Interestingly Marigold gave rise
to a higher percentage of necrotic cells (Fig. 5b). Fig. 5c
Fig. 4 Apoptosis triggered by treatment with Asteraceae plant
extracts on MIA Paca-2 cells. Activation of caspase 3 and 7 after 48 h
treatment with Yarrow SFE extracts (a) or with Marigold SFE extracts
(b), with the positive (Staurosporine 1,5 μM) and negative (Marjoram
SFE 100 μg/mL) controls. Data represent means ± S.E.M of three
independent experiments each performed in duplicate. Asterisks
indicate statistical differences in treated cells with respect to the
control (non-treated cells, DMSO 0.1%). **p < 0.01; ***p < 0.001
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shows a representative flow cytometry plot indicating
the gates for the different subpopulations.
Yarrow and Marigold SFE extracts inhibit colony growth
in 3D
We were interested in determining if Yarrow and Mari-
gold SFE extracts affect the ability of MIA PaCa-2 epi-
thelial cancer cells to form colonies when grown in 3D
culture.
We first plated MIA PaCa-2 in Matrigel and 72 h
later, when the colonies were formed, we treated the
cells with 30, 50 and 70 μg/mL of the extracts, and
the control with DMSO (0.1% v/v) (Fig. 6a). Yarrow
reduced the size and number of the spheres maintain-
ing their integrity (Fig. 6b), while Marigold affected
significantly both parameters when cells were treated
with 70 μg/mL (Fig. 6c), promoting the disruption of
colonies (Fig. 6a). Both extracts diminished colony in-
tegrity suggesting that stem or progenitor cells are
not able to sustain the tumor in vivo when treated
with Yarrow or Marigold.
Yarrow and Marigold SFE extracts exhibit synergizes with
5-FU treatment
Finally, we analyzed the effect of Yarrow SFE and Mari-
gold SFE in combination with the antitumoral drug
5-fluororacil (5-FU) on MIA PaCa-2, which is usually pro-
posed in clinic to treat pancreatic cancer. Cells were
treated with different concentrations of 5-FU for 72 h. We
have observed that both Yarrow and Marigold markedly
potentiate the antiproliferative effect of 5-FU when cells
were pre-treated with these extracts, showing a higher
cytotoxic effect when combining a plant extract with the
antimetabolite 5-FU (Fig. 7), with a significant decrease in
cell viability. Thus, according to the Chou–Talalay method
[16], the combination of Yarrow with 5-FU and the com-
bination of Marigold with 5-FU resulted in a synergistic
effect displaying a (combinatory index) CI value < 1 in
every combination assayed (Fig. 7).
Discussion
In this work, we have evaluated the antitumoral properties
of four plants (Yarrow, Marigold, Balm and Marjoram)
derived extracts in pancreatic cancer cell lines.
Fig. 5 Different phases of cell death after 24 h treatment with Asteraceae plants on MIA Paca-2. The % of apoptotic cells depending on Yarrow
and Marigold SFE extracts (a) and the % of necrotic populations after those treatments (b). A representative flow cytometry diagram (c). Annexin
V-FITC/PI double staining discriminates the live cells (Annexin V−/PI−; bottom left quadrant), early apoptotic cells (Annexin V+/PI−; bottom right
quadrant), late apoptotic (Annexin V+/PI+; upper right quadrant), and necrotic or dead cells (Annexin V−/PI+; upper left quadrant). Data represent
means ± S.E.M of at least four independent experiments each performed in triplicate. Asterisks indicate statistical differences in treated cells with
respect to the control (non-treated cells, DMSO 0.1%). *p < 0.05; ***p < 0.001
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Importantly, two different green technologies have been
used to obtain the bioactive components from these
plants: Supercritical Fluid Extraction (SFE) and Ultrasonic
Assisted Extraction (UAE). For UAE extractions, two dif-
ferent raw materials were compared -the Residual Vege-
table Material obtained after the SFE step (RVM), and the
Original Vegetable Material (OVM)-.
Yarrow and Marigold extracts obtained by SFE were the
most effective ones on inhibiting cell proliferation, exhibit-
ing similar values of IC50, TGI and LC50 in MIA PaCa-2
cells (Table 1). These results are within the range of those
previously reported for Marigold extract obtained by Laser
extraction in pancreatic cancer, leukemia and fibrosarcoma
(IC50 = 60 μg/mL) [12]; or by those obtained by ethyl alco-
hol maceration in melanoma (IC50 = 50 μg/mL) [17].
Yarrow extracts obtained by UAE (Ethanol) from OVM
and RVM were also effective on inhibiting cell viability.
The concentration needed to achieve 50% of growth
inhibition (GI50 = 49,4 ± 25,7 μg/mL) is within the interval
of that obtained in other works by methanolic stirring ex-
traction in hepatocellular (39.02 ± 2.9 μg/mL) and cervical
carcinomas (47.1 ± 1.8 μg/mL) models [18].
Conversely and related to Lamiaceae family plants
(Balm and Marjoram), none of the extracts (nor SFE,
nor UAE) had any effect on the range of concentration
tested (Table 1, Fig. 2). Although it has been described
ethanolic Marjoram extract to promote lymphoblastic
leukemia cell death [19], and Balm extract in hepatocel-
lular and gastric carcinomas [20], in both cases the range
of concentrations were around one thousand times
higher than the ones tested in this work (IC50 = 8 mg/
mL for Marjoram and around 70 mg/mL for Balm).
Thus, Marigold and Yarrow SFE extracts displayed
better dose-dependence activity compared to the UAE
and other extraction methodologies, both in MIA
PaCa-2 and in the more resistant model, PANC-1.
Fig. 6 MIA PaCa-2 response and Combination Index (CI) when cells were pre-treated 8 h with A) Yarrow or B) Marigold, followed by an exposure
of increased doses of 5-FU for 72 h. Data represent means ± S.E.M of at three independent experiments each performed in quadruplicate.
Asterisks (*) indicate statistical differences between 5-FU and Yarrow/Marigold+ 5-FU treatments *p < 0.05; **p < 0.01 ***p < 0.001. # indicates
statistical differences in treated cells with respect to the control (DMSO 0.1%). ### p < 0.001
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Indeed, here, Yarrow and Marigold SFE extracts have
a IC50 dose much higher in a colon non-cancer cell
line (CCD18), comparing the IC50 in a colon cancer
cell line (SW-620) (Additional file 1: Figure S1,
Additional file 1: Table S1), which supports a
therapeutic window for the use of the extracts in
combination with current therapy.
In the other hand, current treatment in clinic is mostly
based on 5-fluorouracil (5-FU) and gemcitabine, even
combined with other drugs. In this sense, we wanted to
determine a possible synergism of Yarrow and Marigold
SFE extracts with 5-FU. Thus, when pre-conditioning
MIA PaCa-2 cells with Yarrow or Marigold, the cytotoxic
effect mediated by the subsequent 5-FU exposure has
been increasing (Fig. 7). This enhancement in 5-FU effect
has been previously described for other SFE extracts, such
as Rosemary in colon cancer model [21], but Yarrow and
Marigold are here described for the first time. In this
sense, this synergism could be considered a promise as a
co-adjuvant treatment, improving patient survival, given
that both extracts potentiate the effect of a first-line che-
motherapeutic agent. Until date, plants extracts, as a
grouped set of molecules, have been tested and used to re-
duce chemotherapy side effects and for improve patient’s
quality of life [22], with few approaches proposing their
use as a second-line therapy [23]. Thus, there is a need to
Fig. 7 Tridimensional MIA PaCa-2 cells when exposed to Asteraceae Extracts. a) Representative images of spheres after Yarrow (up) and Marigold
(down) treatments for 72 h. Sphere number, size and morphology after Yarrow (b) and Marigold (c) exposures. Data represent means ± S.E.M of
three independent experiments each performed in duplicate. Asterisks indicate statistical differences in treated cells with respect to the control
(DMSO, 0.1%) ***p < 0.001; ****p < 0.0001
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promote clinical trials with plant extracts, as an ensemble
of phytochemicals, after validating the antiproliferative hy-
pothesis in murine models.
Further describing the effect of Yarrow and Marigold
SFE extracts, and regarding their mechanism of action,
we have found that both extracts induce apoptosis
through caspase 3/7 cleavage (Fig. 4), although Marigold
has also shown to promote the accumulation of high
levels of a necrotic cell population. These results suggest
that different signaling pathways may be implicated in
the induction of cell death for each extract. In this con-
text, restoring apoptotic signaling pathways has been
proposed as a strategy for cancer treatment. In fact,
most of the antitumoral agents exert their effect through
induction of apoptosis [24, 25]. Particularly, these results
are in accordance with those described previously for
Marigold [12] related with programmed cell death. Con-
cerning Yarrow, there are few studies which describe its
involvement in the induction of apoptosis, contributing
this study to the first evidences of them.
Finally, we also have demonstrated that Yarrow and
Marigold SFE inhibit transforming activity (Fig. 7).
Growing and giving rise to 3D colonies is a way to
monitor cell malignancy and the ability of stem and pro-
genitor cells to sustain the tumor. If the proposed ex-
tracts affect the colony formation, cells are not able to
evade signals that restraint their growth. In this sense,
herein, we have seen that Yarrow induces a
dose-dependent decrease in cell transformation and
brakes the 3D sphere growth, while, Marigold induces
disruption of the integrity of 3D colonies that may be
due to the loose of their mesenchymal phenotype associ-
ated with an increased motility.
These results also suggest differences in the specific
antitumoral mechanism of both extracts. They demon-
strate that even both plants are from the same family
(Asteraceae), there are differences in the way they exert
their bioactive effect against pancreatic tumor cells.
These differences encourage further studies to better
understand the molecular action of the extracts, con-
ducting individual approaches for each plant type. Once
we a deeper understanding of their anticancer profile
reached, the extracts could be registered for this pur-
pose, beyond their current use as herbal preparation in
most of the European Union countries.
Conclusion
This work has demonstrated that Yarrow and Marigold
supercritical fluid extracts (SFE), besides avoiding chemical
agents for their obtaining, allow to get effective amounts of
antitumor phytochemical agents with effects not only in
cell viability and 3D grown, but also in sensitizing tumor
cells to chemotherapeutic agents such as 5-FU.
Related to Marjoram and Balm, their derived extracts
have shown no cytotoxic effect in the pancreatic cell
lines tested.
Additional file
Additional file 1: Table S1. Sensitivity of SW-620 human colon cancer
cells and CCD18 colon cells to Yarrow and Marigold extracts. Concentrations
required to achieve the IC50, LC50, IG50 and TGI of Yarrow and Marigold
SFE extracts treatments in colorrectal derived cancer cells and non tumoral
colon cells. Figure S1. Dose-response curves of cell viability assays after
48 h treatment of SW-620 colon cancer cells (A) versus CCD18 non-cancer
cells (B) with increasing concentrations of Yarrow and Marigold SFE extracts.
Dose-response curves of cancer and non-cancer colon cells after treatments
with Yarrow and Marigold SFE extracts. (DOCX 151 kb)
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